Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;4(3):174-91.
doi: 10.1016/j.molonc.2010.04.011. Epub 2010 May 21.

Genetic susceptibility to breast cancer

Affiliations
Review

Genetic susceptibility to breast cancer

Nasim Mavaddat et al. Mol Oncol. 2010 Jun.

Abstract

Genetic and lifestyle/environmental factors are implicated in the aetiology of breast cancer. This review summarizes the current state of knowledge on rare high penetrance mutations, as well as moderate and low-penetrance genetic variants implicated in breast cancer aetiology. We summarize recent discoveries from large collaborative efforts to combine data from candidate gene studies, and to conduct genome-wide association studies (GWAS), primarily in breast cancers in the general population. These findings are compared with results from collaborative efforts aiming to identify genetic modifiers in BRCA1 and BRCA2 carriers. Breast cancer is a heterogeneous disease, and tumours from BRCA1 and BRCA2 carriers display distinct pathological characteristics when compared with tumours unselected for family history. The relationship between genetic variants and pathological subtypes of breast cancer, and the implication of discoveries of novel genetic variants to risk prediction in BRCA1/2 mutation carriers and in populations unselected for mutation carrier status, are discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Susceptibility loci in ER‐positive and ER‐negative disease in the general population, and in BRCA1 and BRCA2 carriers. Data from published studies of Easton et al. (Easton et al., 2007; Garcia‐Closas et al., 2008); Milne et al. (2009); Zheng et al. (2009b); Thomas et al. (2009); Ahmed et al. (2009); Cox et al. (2007); Stacey et al. (2008) and Antoniou et al. (2008b); Antoniou et al. (2009).
Figure 2
Figure 2
Cumulative risk of breast cancer for BRCA2 mutation carriers and general population by combined FGFR2 and TOX3 genotypes. The combined FGFR2 genotypes at extremes of risk are as follow: FGFR2/TOX3 = GG/CC, or FGFR2/TOX3 = AA/TT. “Average” represents the cumulative breast cancer risk over all possible modifying effects among BRCA2 mutation carriers, or individuals in the general population born after 1950 (Parkin et al., 2002). The minor allele frequencies for the FGFR2 and TOX3 SNPs were assumed to be 0.39 and 0.26 respectively (adapted from Antoniou et al., 2008b).

Similar articles

Cited by

References

    1. van 't Veer, L.J. , Dai, H. , Van De Vijver, M.J. , He, Y.D. , Hart, A.A. , Mao, M. , Peterse, H.L. , van der Kooy, K. , Marton, M.J. , Witteveen, A.T. , Schreiber, G.J. , Kerkhoven, R.M. , Roberts, C. , Linsley, P.S. , Bernards, R. , Friend, S.H. , 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415, 530–536. - PubMed
    1. Adnane, J. , Gaudray, P. , Dionne, C.A. , Crumley, G. , Jaye, M. , Schlessinger, J. , Jeanteur, P. , Birnbaum, D. , Theillet, C. , 1991. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene. 6, 659–663. - PubMed
    1. Ahmed, S. , Thomas, G. , Ghoussaini, M. , Healey, C.S. , Humphreys, M.K. , Platte, R. , Morrison, J. , Maranian, M. , Pooley, K.A. , Luben, R. , Eccles, D. , Evans, D.G. , Fletcher, O. , Johnson, N. , dos SS, I. , Peto, J. , Stratton, M.R. , Rahman, N. , Jacobs, K. , Prentice, R. , Anderson, G.L. , Rajkovic, A. , Curb, J.D. , Ziegler, R.G. , Berg, C.D. , Buys, S.S. , McCarty, C.A. , Feigelson, H.S. , Calle, E.E. , Thun, M.J. , Diver, W.R. , Bojesen, S. , Nordestgaard, B.G. , Flyger, H. , Dork, T. , Schurmann, P. , Hillemanns, P. , Karstens, J.H. , Bogdanova, N.V. , Antonenkova, N.N. , Zalutsky, I.V. , Bermisheva, M. , Fedorova, S. , Khusnutdinova, E. , Kang, D. , Yoo, K.Y. , Noh, D.Y. , Ahn, S.H. , Devilee, P. , van Asperen, C.J. , Tollenaar, R.A. , Seynaeve, C. , Garcia-Closas, M. , Lissowska, J. , Brinton, L. , Peplonska, B. , Nevanlinna, H. , Heikkinen, T. , Aittomaki, K. , Blomqvist, C. , Hopper, J.L. , Southey, M.C. , Smith, L. , Spurdle, A.B. , Schmidt, M.K. , Broeks, A. , van Hien, R.R. , Cornelissen, S. , Milne, R.L. , Ribas, G. , Gonzalez-Neira, A. , Benitez, J. , Schmutzler, R.K. , Burwinkel, B. , Bartram, C.R. , Meindl, A. , Brauch, H. , Justenhoven, C. , Hamann, U. , Chang-Claude, J. , Hein, R. , Wang-Gohrke, S. , Lindblom, A. , Margolin, S. , Mannermaa, A. , Kosma, V.M. , Kataja, V. , Olson, J.E. , Wang, X. , Fredericksen, Z. , Giles, G.G. , Severi, G. , Baglietto, L. , English, D.R. , Hankinson, S.E. , Cox, D.G. , Kraft, P. , Vatten, L.J. , Hveem, K. , Kumle, M. , Sigurdson, A. , Doody, M. , Bhatti, P. , Alexander, B.H. , Hooning, M.J. , van den Ouweland, A.M. , Oldenburg, R.A. , Schutte, M. , Hall, P. , Czene, K. , Liu, J. , Li, Y. , Cox, A. , Elliott, G. , Brock, I. , Reed, M.W. , Shen, C.Y. , Yu, J.C. , Hsu, G.C. , Chen, S.T. , Anton-Culver, H. , Ziogas, A. , Andrulis, I.L. , Knight, J.A. , Beesley, J. , Goode, E.L. , Couch, F. , Chenevix-Trench, G. , Hoover, R.N. , Ponder, B.A. , Hunter, D.J. , Pharoah, P.D. , Dunning, A.M. , Chanock, S.J. , Easton, D.F. , 2009. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat. Genet. 41, 585–590. - PMC - PubMed
    1. Amend, K. , Hicks, D. , Ambrosone, C.B. , 2006. Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res. 66, 8327–8330. - PubMed
    1. Amundadottir, L.T. , Thorvaldsson, S. , Gudbjartsson, D.F. , Sulem, P. , Kristjansson, K. , Arnason, S. , Gulcher, J.R. , Bjornsson, J. , Kong, A. , Thorsteinsdottir, U. , Stefansson, K. , 2004. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med. 1, e65 229–236 - PMC - PubMed